We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

In September 2024, Prime Medicine entered into a strategic research collaboration and license agreement with Bristol Myers Squibb to develop and commercialize multiple Prime Edited ex vivo T-cell ...

Collaboration Combines Prime Medicine’s Precise, Multiplex Gene Editing Capabilities with Bristol Myers Squibb’s Broad Expertise in Development and Commercialization of Novel Cell Therapies ...

Bristol-Myers Squibb's stock price has risen more than 25% over the past six months, reflecting significant progress in its ...

Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Bristol-Myers Squibb Co (NYSE:BMY) shares are trading higher Monday. The stock appears to be reacting positively after AbbVie ...

2024 The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. Bristol Myers ...

Sanofi and Bristol-Myers Squibb have announced they are restructuring ... blood thinner Plavix and hypertension medicine Avapro/Avalide, and the arrival of generic competition in many major ...

White House says The "imposed" Eliquis price "does not reflect the substantial clinical and economic value of this essential medicine," Bristol Myers Squibb said in August. The company has said it ...

The Bristol Myers Squibb Foundation, an independent charitable organization, has awarded Baylor College of Medicine Global Health $2.25 million for the Comprehensive Cervical Cancer Pilot Initiative ...